Par Drugs and Chemicals Limited

NSE PAR.NS

Par Drugs and Chemicals Limited Free Cash Flow Yield on January 31, 2025: 6.19%

Par Drugs and Chemicals Limited Free Cash Flow Yield is 6.19% on January 31, 2025, a 167.46% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

Par Drugs and Chemicals Limited 52-week high Free Cash Flow Yield is 6.55% on January 13, 2025, which is 5.83% above the current Free Cash Flow Yield.
Par Drugs and Chemicals Limited 52-week low Free Cash Flow Yield is 2.08% on February 16, 2024, which is -66.33% below the current Free Cash Flow Yield.
Par Drugs and Chemicals Limited average Free Cash Flow Yield for the last 52 weeks is 4.47%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

NSE: PAR.NS

Par Drugs and Chemicals Limited

CEO	Mr. Jignesh Vallabhbhai Savani
IPO Date	May 30, 2019
Location	India
Headquarters	816, Nilamber Triumph
Employees	122
Sector	Materials
Industries Glass Chemicals & Advanced Materials Cleaning Supplies Composite Materials Cosmetics Personal Care Petrochemicals Plastics

Description

Par Drugs and Chemicals Limited develops, produces, and sells active pharma ingredients and fine chemicals in India. It offers magnesium salts, dried aluminum hydroxide gel, sodium aluminum silicate, precipitated silica, magnesium silicate, colloidal silicon dioxide, sucralfate USP, and amorphous and blended products. The company also exports its products. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.

Key trends

Past 5 years